vs
CareDx, Inc.（CDNA）与RCI HOSPITALITY HOLDINGS, INC.（RICK）财务数据对比。点击上方公司名可切换其他公司
CareDx, Inc.的季度营收约是RCI HOSPITALITY HOLDINGS, INC.的1.7倍（$117.7M vs $70.9M），CareDx, Inc.净利率更高（2.4% vs -7.8%，领先10.1%），CareDx, Inc.同比增速更快（39.0% vs -3.1%），RCI HOSPITALITY HOLDINGS, INC.自由现金流更多（$11.5M vs $514.0K），过去两年CareDx, Inc.的营收复合增速更高（12.9% vs -2.0%）
CareDx是一家专注于器官移植领域的精准医疗企业，核心产品包括移植排斥反应监测诊断试剂、数字健康管理工具及配套临床服务，面向北美和欧洲市场的医疗机构及移植患者，助力提升术后患者生存质量。
RCI Hospitality控股通过子公司经营脱衣舞俱乐部、夜总会、运动酒吧与餐厅，同时还运营一家为成人俱乐部行业提供服务的传媒会展企业。公司于1995年完成首次公开募股上市，目前在纳斯达克全球市场挂牌交易。
CDNA vs RICK — 直观对比
营收规模更大
CDNA
是对方的1.7倍
$70.9M
营收增速更快
CDNA
高出42.1%
-3.1%
净利率更高
CDNA
高出10.1%
-7.8%
自由现金流更多
RICK
多$11.0M
$514.0K
两年增速更快
CDNA
近两年复合增速
-2.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $117.7M | $70.9M |
| 净利润 | $2.8M | $-5.5M |
| 毛利率 | — | — |
| 营业利润率 | 1.0% | -0.7% |
| 净利率 | 2.4% | -7.8% |
| 营收同比 | 39.0% | -3.1% |
| 净利润同比 | — | -2354.9% |
| 每股收益（稀释后） | $0.05 | $-0.60 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CDNARICK
| Q1 26 | $117.7M | — | ||
| Q4 25 | $108.4M | — | ||
| Q3 25 | $100.1M | $70.9M | ||
| Q2 25 | $86.7M | $71.1M | ||
| Q1 25 | $84.7M | $65.9M | ||
| Q4 24 | $86.6M | $71.5M | ||
| Q3 24 | $82.9M | $73.2M | ||
| Q2 24 | $92.3M | $76.2M |
净利润CDNARICK
| Q1 26 | $2.8M | — | ||
| Q4 25 | $-4.1M | — | ||
| Q3 25 | $1.7M | $-5.5M | ||
| Q2 25 | $-8.6M | $4.1M | ||
| Q1 25 | $-10.4M | $3.2M | ||
| Q4 24 | $87.7M | $9.0M | ||
| Q3 24 | $-10.6M | $244.0K | ||
| Q2 24 | $-4.6M | $-5.2M |
营业利润率CDNARICK
| Q1 26 | 1.0% | — | ||
| Q4 25 | -5.6% | — | ||
| Q3 25 | -0.2% | -0.7% | ||
| Q2 25 | -12.8% | 12.2% | ||
| Q1 25 | -15.8% | 12.4% | ||
| Q4 24 | 97.5% | 19.5% | ||
| Q3 24 | -16.6% | 4.8% | ||
| Q2 24 | -7.9% | -3.3% |
净利率CDNARICK
| Q1 26 | 2.4% | — | ||
| Q4 25 | -3.8% | — | ||
| Q3 25 | 1.7% | -7.8% | ||
| Q2 25 | -9.9% | 5.7% | ||
| Q1 25 | -12.2% | 4.9% | ||
| Q4 24 | 101.3% | 12.6% | ||
| Q3 24 | -12.8% | 0.3% | ||
| Q2 24 | -5.0% | -6.9% |
每股收益（稀释后）CDNARICK
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-0.08 | — | ||
| Q3 25 | $0.03 | $-0.60 | ||
| Q2 25 | $-0.16 | $0.46 | ||
| Q1 25 | $-0.19 | $0.36 | ||
| Q4 24 | $1.60 | $1.01 | ||
| Q3 24 | $-0.20 | $0.04 | ||
| Q2 24 | $-0.09 | $-0.56 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $77.9M | $33.7M |
| 总债务越低越好 | — | $238.2M |
| 股东权益账面价值 | — | $261.1M |
| 总资产 | $411.1M | $596.9M |
| 负债/权益比越低杠杆越低 | — | 0.91× |
8季度趋势，按日历期对齐
现金及短期投资CDNARICK
| Q1 26 | $77.9M | — | ||
| Q4 25 | $177.2M | — | ||
| Q3 25 | $194.2M | $33.7M | ||
| Q2 25 | $186.3M | $29.3M | ||
| Q1 25 | $230.9M | $32.7M | ||
| Q4 24 | $260.7M | $34.7M | ||
| Q3 24 | $240.9M | $32.4M | ||
| Q2 24 | $228.9M | $34.9M |
总债务CDNARICK
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $238.2M | ||
| Q2 25 | — | $243.8M | ||
| Q1 25 | — | $244.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | $0 | $241.1M | ||
| Q2 24 | $0 | — |
股东权益CDNARICK
| Q1 26 | — | — | ||
| Q4 25 | $303.1M | — | ||
| Q3 25 | $311.1M | $261.1M | ||
| Q2 25 | $327.4M | $269.5M | ||
| Q1 25 | $379.3M | $268.8M | ||
| Q4 24 | $378.4M | $269.0M | ||
| Q3 24 | $273.2M | $263.4M | ||
| Q2 24 | $264.7M | $271.2M |
总资产CDNARICK
| Q1 26 | $411.1M | — | ||
| Q4 25 | $413.2M | — | ||
| Q3 25 | $432.3M | $596.9M | ||
| Q2 25 | $444.3M | $597.4M | ||
| Q1 25 | $489.6M | $589.8M | ||
| Q4 24 | $491.1M | $586.2M | ||
| Q3 24 | $477.0M | $584.4M | ||
| Q2 24 | $466.8M | $601.0M |
负债/权益比CDNARICK
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.91× | ||
| Q2 25 | — | 0.90× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.00× | 0.92× | ||
| Q2 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.3M | $13.7M |
| 自由现金流经营现金流 - 资本支出 | $514.0K | $11.5M |
| 自由现金流率自由现金流/营收 | 0.4% | 16.2% |
| 资本支出强度资本支出/营收 | — | 3.2% |
| 现金转化率经营现金流/净利润 | 1.54× | — |
| 过去12个月自由现金流最近4个季度 | — | $34.9M |
8季度趋势，按日历期对齐
经营现金流CDNARICK
| Q1 26 | $4.3M | — | ||
| Q4 25 | $21.4M | — | ||
| Q3 25 | $37.4M | $13.7M | ||
| Q2 25 | $9.9M | $13.8M | ||
| Q1 25 | $-26.6M | $8.5M | ||
| Q4 24 | $21.9M | $13.3M | ||
| Q3 24 | $12.5M | $15.7M | ||
| Q2 24 | $18.9M | $15.8M |
自由现金流CDNARICK
| Q1 26 | $514.0K | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $11.5M | ||
| Q2 25 | — | $10.1M | ||
| Q1 25 | — | $5.7M | ||
| Q4 24 | — | $7.6M | ||
| Q3 24 | — | $10.3M | ||
| Q2 24 | — | $9.3M |
自由现金流率CDNARICK
| Q1 26 | 0.4% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 16.2% | ||
| Q2 25 | — | 14.2% | ||
| Q1 25 | — | 8.6% | ||
| Q4 24 | — | 10.6% | ||
| Q3 24 | — | 14.0% | ||
| Q2 24 | — | 12.3% |
资本支出强度CDNARICK
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | — | 5.2% | ||
| Q1 25 | — | 4.3% | ||
| Q4 24 | — | 8.0% | ||
| Q3 24 | — | 7.3% | ||
| Q2 24 | — | 8.4% |
现金转化率CDNARICK
| Q1 26 | 1.54× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 22.30× | — | ||
| Q2 25 | — | 3.40× | ||
| Q1 25 | — | 2.65× | ||
| Q4 24 | 0.25× | 1.48× | ||
| Q3 24 | — | 64.14× | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CDNA
| Financial Results Total | $85.0M | 72% |
| Patient and digital solutions revenue | $16.0M | 14% |
| Product revenue | $10.3M | 9% |
| Other | $6.4M | 5% |
RICK
| Transferred At Point In Time | $60.8M | 86% |
| Food And Merchandise | $10.4M | 15% |
